Biopharm,
With respect to you, being optimistic is terribly difficult concerning Peregrine. Bfiest's recent conversation with IR confirms this. At this point and time, positive outcomes look to be years out. My only hope is a partner does understand the real potential of Bavi and offers fair market value for it, whatever that may be.
I have enough faith in Bavi, but not the people who run the company. Therefore we have a conundrum.
I don't like that much.
Jmo
Loofman
News 
Market Data 
Discover 
